10 CRO Oversight Companies for Clinical Trials in 2026

Handing a clinical trial to a CRO doesn't remove a sponsor's responsibility for how it's run. Regulators still expect the sponsor to show governance over regulatory and GCP compliance, quality management, risk-based monitoring, site and vendor oversight, financial management, and inspection readiness — even when the day-to-day work sits with a contracted partner. CRO oversight companies help sponsors build and evidence that governance, whether by running the trial to a documented quality management system or by independently auditing the CRO doing the work.

The companies on this list offer CRO oversight capabilities for clinical trials, spanning independent GCP auditing, clinical quality management systems, and full-service CROs with documented governance track records across site monitoring, vendor management, and regulatory inspections. This is an unranked list — the order carries no judgment about quality or fit. Diligent's own database has no dedicated keyword set for this category, so the terms above reflect our own read of what sponsors mean by CRO oversight rather than a matched search term.

GXP Engaged Auditing Services

GXP Engaged Auditing Services runs a global QA auditing and consultancy practice with more than 300 auditors operating across 65-plus countries, covering GCP, GLP, GCLP, GMP/GDP, and GVP audits. Its services span single audits through full annual audit programme management, QMS development and optimization, and complete inspection readiness programmes, giving sponsors flexible oversight of development activities from pre-clinical through post-marketing. The company operates from Munich, with additional offices in the UK, the US, and Austria.

HEMEX

HEMEX holds ISO 9001:2015 and ISO 13485:2016 Quality Management System certifications alongside ICH-GCP E6 certification, and states its Quality Assurance team has a demonstrated history of successful inspections by major regulatory authorities worldwide. Founded in 2015 and based in Liestal, Switzerland, the company has since expanded into Germany and the US, and recently formed a Global Clinical Network Alliance to extend its end-to-end CRO capabilities in oncology, medical imaging, and patient recruitment. HEMEX also offers regulatory affairs, CMC, project management, and data and documentation management services to biotech and medical device companies.

InClin

InClin's full suite of clinical development services explicitly includes vendor management and QA inspection readiness alongside project management, clinical monitoring, and site and contract management. The company was the subject of a Quasar publication on the first virtual inspection conducted by the European Medicines Agency, reflecting its work navigating regulatory inspection formats as they evolve. Founded in 1998 and based in San Mateo, California, InClin also operates an office in Sydney, Australia, delivering Phase 1 through Phase 4 services as a single source provider.

Pharmnet

Pharmnet's services include contracting central labs and administration of investigator payments alongside regulatory submission, monitoring, and audits of study sites, giving sponsors a documented financial and compliance trail across a trial. The company states a history of successful inspections from the FDA, MHRA, Health Canada, and several European regulatory bodies across more than 660 projects. Founded in 1994 and headquartered in Prague, Czech Republic, Pharmnet expanded its European footprint in 2024 through the acquisition of MONIPOL Biotech, adding operations in Poland, Germany, Slovakia, and Hungary.

Prodia the CRO

Prodia the CRO is the only fully integrated local CRO in Indonesia to combine CRO, Site Management Organization, and central laboratory capabilities under one roof, an integration Frost & Sullivan has recognized for its customer focus and leadership. The company's central laboratory holds accreditation from the College of American Pathologists, supporting global trials that require in-country sample testing under Indonesian regulations. Evolved from Prodia Clinical Laboratory, founded in 1973, into a CRO in 2008, the company is based in Jakarta and delivers Good Clinical Practice-based clinical trials across diverse therapeutic areas.

Norwich Clinical Research Associates (NCRA)

NCRA specializes in clinical operations, trial management, monitoring, data management, and auditing, and states its work meets the ICH's Good Clinical Practice E6 guideline. Founded in 1994, the company reports that roughly two-thirds of its contracts are repeat business, and it serves the pharmaceutical, medical device, and nutraceutical industries from pre- and post-marketing studies through final regulatory reports. NCRA is based in New Jersey and positions its integrated service modules as a cost-effective, full-service alternative for product development programs.

Prevail Infoworks

Prevail Infoworks operates as a full-service CRO/FSP built around its Single Interface platform, which integrates clinical, diagnostic, operational, and financial data from a study into one real-time view for sponsors and CROs. The company states it has supported clinical services and technologies across eight FDA product approvals, spanning clinical monitoring, safety data management, and site and contract coordination. Founded in 2005 and based in Philadelphia, Pennsylvania, Prevail Infoworks also provides pharmacovigilance and real-time data analytics as part of its oversight-oriented service model.

Excelya

Excelya runs a Quality Management System with ISO 9001 and ISO 27001 coverage, backed by a track record of more than 200 client audits and 20 regulatory authority inspections. Sponsors can choose Full Service, FSP, or Resourcing engagement models, and the company's clinical operations staff explicitly manage site and vendor oversight, RFP processes, and CRO selection on sponsors' behalf. Founded in 2014 and headquartered in Boulogne-Billancourt, France, Excelya has grown to more than 1,000 experts across 16 offices and 25-plus countries, supporting over 550 clinical trials from Phase I through IV.

Leslie Sam & Associates

Leslie Sam & Associates is built around the clinical quality management system (CQMS) expertise of its founder, who was sought by TransCelerate BioPharma to co-develop and co-author the industry's conceptual frameworks for CQMS and issue management. The firm applies risk-based quality management (RBQM) and Six Sigma methodology to help organizations design and implement clinical quality systems that support data integrity, patient safety, and regulatory compliance. Leslie Sam, the firm's president, also served as a reviewer of TransCelerate's conceptual risk management framework and is based in the United States.

A-Pharma

A-Pharma offers clinical evaluations, drug registrations, and audits alongside biostatistics and regulatory affairs support, and holds ISO 9001:2000 certification for its clinical evaluation activities. Founded in 1996 and headquartered in Prague, the company has completed more than 150 clinical evaluations across therapeutic areas including hypertension, bronchial asthma, neurological disorders, and diabetes. A-Pharma operates throughout the Czech Republic and Slovakia, positioning itself as a leading private research organization in the local market.

Explore the full CRO oversight landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 350 CRO Oversight Vendors, many with Vendor qualification data available on demand. Book a demo to explore Diligent's full vendor discovery database.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.